part iii item 10 . directors and executive officers of the registrant . the information required by this item is incorporated by reference to the sections entitled 201celection of directors 201d and 201cexecutive officers 201d in our definitive proxy statement for our annual meeting of stockholders to be filed with the securities and exchange commission within 120 days after the close of our fiscal year . item 11 . executive compensation . the information required by this item is incorporated by reference to the sections entitled 201cexecutive compensation 201d in our definitive proxy statement for our annual meeting of stockholders to be filed with the securities and exchange commission within 120 days after the close of our fiscal year . item 12 . security ownership of certain beneficial owners and management and related stockholder matters . we maintain a number of equity compensation plans for employees , officers , directors and others whose efforts contribute to our success . the table below sets forth certain information as our fiscal year ended september 27 , 2003 regarding the shares of our common stock available for grant or granted under stock option plans that ( i ) were approved by our stockholders , and ( ii ) were not approved by our stockholders . equity compensation plan information plan category number of securities to be issued upon exercise of outstanding options , warrants and rights weighted-average exercise price of outstanding options , warrants and rights number of securities remaining available for future issuance under equity compensation plans ( excluding securities reflected in column ( a ) ) equity compensation plans approved by security holders ( 1 ) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2111138 $ 9.25 826200 equity compensation plans not approved by security holders ( 2 ) . . . . . . . . . . . . . . . . . . . . . . . . . 1116615 $ 8.12 535257 .

Table: plan category number of securities to be issued upon exerciseof outstanding options warrants and rights ( a ) weighted-average exercise price of outstanding options warrantsand rights ( b ) number of securities remaining available for future issuance underequity compensation plans ( excluding securities reflected in column ( a ) ) ( c ) equity compensation plans approved by security holders ( 1 ) 2111138 $ 9.25 826200 equity compensation plans not approved by security holders ( 2 ) 1116615 $ 8.12 535257 total 3227753 $ 8.86 1361457

( 1 ) includes the following plans : 1986 combination stock option plan ; amended and restated 1990 non- employee director stock option plan ; 1995 combination stock option plan ; amended and restated 1999 equity incentive plan ; and 2000 employee stock purchase plan . also includes the following plans which we assumed in connection with our acquisition of fluoroscan imaging systems in 1996 : fluoroscan imaging systems , inc . 1994 amended and restated stock incentive plan and fluoroscan imaging systems , inc . 1995 stock incentive plan . for a description of these plans , please refer to footnote 6 contained in our consolidated financial statements . ( 2 ) includes the following plans : 1997 employee equity incentive plan and 2000 acquisition equity incentive plan . a description of each of these plans is as follows : 1997 employee equity incentive plan . the purposes of the 1997 employee equity incentive plan ( the 201c1997 plan 201d ) , adopted by the board of directors in may 1997 , are to attract and retain key employees , consultants and advisors , to provide an incentive for them to assist us in achieving long-range performance goals , and to enable such person to participate in our long-term growth . in general , under the 1997 plan , all employees , consultants , and advisors who are not executive officers or directors are eligible to participate in the 1997 plan . the 1997 plan is administered by a committee consisting of at least three members of the board appointed by the board of directors . participants in the 1997 plan are eligible to receive non-qualified stock options , stock .

Question: if all outstanding options warrants and rights were exercised what would be the total cash inflow?
Answer: 28597891.58
Calculation: multiply(8.86, 3227753)
Explanation: this provides the cash impact of the exercise and can be judged against dilution as well as used for future cash flow modeling .